This indigenous drug has been around for quite long and tall claims have been made by its inventors about its efficacy for curing a wide variety of ailments - many of them peculiar to India. However there was always a dearth of willing subjects in adequate numbers to participate in a trial that could establish the claims. Quite a few patients also claimed to be allergic towards it.
Later on, somehow, the number of willing patients rose to a statistically very significant number in a state that is known for its enterprise. The trials there have been claimed to be a resounding success that established all the claims of the inventors and then some more. The competing firms, however, kept pointing out that the observed effects were more due to the disciplined lifestyle of the participants rather than the drug itself. One newly established firm conducted its own research and maintained that though there were some improvements in the musculature and skin tone, functioning of the internal organs continued to be at sub-optimal levels.
In the meantime large number of patients throughout the country were getting disillusioned with established drugs from the best-known brand in the country. Complaints were made of loss of general vitality accompanied by impaired vocal chords. Moreover rising prices were making the drug very unaffordable. There also was a suspicion of huge profits being siphoned offshore by this firm.
A sizable number of these disillusioned patients in another state, decided to try a drug that had been invented very recently. The response was very good but the patients were too impatient. To make things worse, the firm stopped production claiming that its competitors had blocked the supply of a vital input.
In the meantime inventors of SutoL claimed to have found a very potent molecule that they have named O-maN. The addition of this molecule has significantly enhanced the potency of the old formulation. Some of the ingredients in the earlier formulation have also been dropped as they were found to be interfering with the efficacy of the new molecule.
Left with no choice and with reports of the new formulation under the old brand name SutoL, the patients have shifted en masse to the indigenous drug. The trials have begun with much fanfare. The market share of competitors who had a near monopoly in the market has seen a sharp plunge.
The latest entrant in the market who had to stop production because of non-availability of a critical ingredient, are sticking to their claim that this new so-called wonder drug is essentially similar to the brand that it has displaced. Unfortunately they find few takers.
The newly begun trials have evoked keen interest all over the world. We offer our very best wishes to the participants in the trials as also the makers of this drug.
Later on, somehow, the number of willing patients rose to a statistically very significant number in a state that is known for its enterprise. The trials there have been claimed to be a resounding success that established all the claims of the inventors and then some more. The competing firms, however, kept pointing out that the observed effects were more due to the disciplined lifestyle of the participants rather than the drug itself. One newly established firm conducted its own research and maintained that though there were some improvements in the musculature and skin tone, functioning of the internal organs continued to be at sub-optimal levels.
In the meantime large number of patients throughout the country were getting disillusioned with established drugs from the best-known brand in the country. Complaints were made of loss of general vitality accompanied by impaired vocal chords. Moreover rising prices were making the drug very unaffordable. There also was a suspicion of huge profits being siphoned offshore by this firm.
A sizable number of these disillusioned patients in another state, decided to try a drug that had been invented very recently. The response was very good but the patients were too impatient. To make things worse, the firm stopped production claiming that its competitors had blocked the supply of a vital input.
In the meantime inventors of SutoL claimed to have found a very potent molecule that they have named O-maN. The addition of this molecule has significantly enhanced the potency of the old formulation. Some of the ingredients in the earlier formulation have also been dropped as they were found to be interfering with the efficacy of the new molecule.
Left with no choice and with reports of the new formulation under the old brand name SutoL, the patients have shifted en masse to the indigenous drug. The trials have begun with much fanfare. The market share of competitors who had a near monopoly in the market has seen a sharp plunge.
The latest entrant in the market who had to stop production because of non-availability of a critical ingredient, are sticking to their claim that this new so-called wonder drug is essentially similar to the brand that it has displaced. Unfortunately they find few takers.
The newly begun trials have evoked keen interest all over the world. We offer our very best wishes to the participants in the trials as also the makers of this drug.
congrats on this R&A on the new drug. ....hope the drug is as effective...tseb sehsiw....
ReplyDelete